CCL5 and Hepatic fibrosis: CCR1 knockout mouse models display no alteration in wound healing [98], while intraperitoneal infusion of the CCL5 antagonist Met-CCL5 was shown to improve liver fibrosis in mice and accelerate regression of fibrosis [99].